Merck to Lower Prices on Some Drugs, but Not its Blockbusters by KATIE THOMAS


The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.

Published: July 19, 2018 at 02:00AM

from NYT Health https://ift.tt/2zVJlJc